Spellman David A 4
4 · Akebia Therapeutics, Inc. · Filed Apr 1, 2021
Insider Transaction Report
Form 4
Spellman David A
SVP, CFO and Treasurer
Transactions
- Sale
Common Stock
2021-04-01$3.40/sh−790$2,686→ 76,802 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.